Data / Form D filings / Peytant Solutions, Inc.
Peytant Solutions, Inc.: Form D filings
Peytant Solutions, Inc., a biotechnology company in Plymouth, MN, filed 7 Form D notices with the SEC between 2015 and 2025. The latest, on January 10, 2025, reports $2.9 million sold of a $5 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3650 Annapolis Lane, #180, Plymouth, MN, 55447
- Phone
- (612) 790-2555
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Minnesota
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1652372
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 10, 2025 | Amendment | $5,000,000 | $2,890,724 | $2,109,276 | 19 | Feb 6, 2023 | sec.gov |
| Jan 11, 2024 | Amendment | $5,000,000 | $1,545,000 | $3,455,000 | 8 | Feb 6, 2023 | sec.gov |
| Feb 22, 2023 | New notice | $3,000,000 | $900,000 | $2,100,000 | 3 | Feb 6, 2023 | sec.gov |
| Mar 24, 2021 | New notice | $2,008,031 | $275,005 | $1,733,026 | 3 | Mar 9, 2021 | sec.gov |
| Oct 26, 2017 | Amendment | $4,000,000 | $1,160,000 | $2,840,000 | 11 | Jul 27, 2017 | sec.gov |
| Aug 31, 2017 | New notice | $4,000,000 | $860,000 | $3,140,000 | 7 | Jul 27, 2017 | sec.gov |
| Sep 3, 2015 | New notice | $3,000,001 | $576,504 | $2,423,497 | 8 | Aug 19, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Schorgl | Executive Officer, Director, Promoter | |
| Bruce Faulken | Director | |
| Craig Walker | Director | |
| Steven Healy | Director | |
| Clay Anselmo | Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Jan 6, 2025 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Peytant Solutions, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.